Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 2:44 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 532834 | NSE: CAMLINFINE

Camlin Fine Sciences Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 2:44 am

Market Cap 1,951 Cr.
Current Price 102
Intrinsic Value₹3,099.38
High / Low 335/96.2
Stock P/E822
Book Value 46.3
Dividend Yield0.00 %
ROCE11.0 %
ROE15.0 %
Face Value 1.00
PEG Ratio-24.56

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Camlin Fine Sciences Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Camlin Fine Sciences Ltd 1,951 Cr. 102 335/96.2822 46.30.00 %11.0 %15.0 % 1.00
Thirumalai Chemicals Ltd 2,171 Cr. 180 329/158 1270.00 %0.26 %4.13 % 1.00
Rossari Biotech Ltd 2,239 Cr. 404 768/37316.3 2260.12 %15.8 %12.2 % 2.00
Panama Petrochem Ltd 1,547 Cr. 256 411/2298.33 2221.96 %20.4 %15.9 % 2.00
Fineotex Chemical Ltd 2,428 Cr. 20.8 35.8/19.025.0 6.720.38 %23.8 %18.4 % 1.00
Industry Average12,530.04 Cr712.4964.87182.870.55%12.98%25.40%6.41

All Competitor Stocks of Camlin Fine Sciences Ltd

Quarterly Result

MetricSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales 483388427420406386377381417431437424460
Expenses 428338383381381363345352366375378405427
Operating Profit 55504439252331295256591933
OPM % 11%13%10%9%6%6%8%8%12%13%14%4%7%
Other Income 310-8622-96-15-151-8-173-4
Interest 18121010201416232634161619
Depreciation 14161819192113151714181719
Profit before tax 2632816-12-10-94-23-142-08-11-9
Tax % 61%28%59%25%72%47%-13%48%-18%2,164%99%-0%65%
Net Profit 1023312-21-14-82-35-116-70-11-15
EPS in Rs 0.741.360.520.83-1.03-0.63-4.11-1.81-5.33-0.22-0.04-0.53-0.76

Last Updated: January 2, 2026, 4:03 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 23, 2026, 4:46 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 5095584895347218921,0491,1871,4121,6821,4541,6671,778
Expenses 4464743975027058199141,0001,2541,4711,2841,4471,645
Operating Profit 638492321673135187158211170220133
OPM % 12%15%19%6%2%8%13%16%11%13%12%13%8%
Other Income 99-11412143533-4-142-203-42
Interest 252424313241484241647011169
Depreciation 12161722272933445663566471
Profit before tax 355350-6-3117581059480-99-158-49
Tax % 18%-4%28%-26%-22%82%49%38%36%50%6%0%
Net Profit 295536-4-24330656040-105-158-63
EPS in Rs 2.715.113.30-0.96-2.180.042.233.563.452.96-4.94-7.40-3.22
Dividend Payout % 12%8%12%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

Growth

Compounded Sales Growth
10 Years:12%
5 Years:10%
3 Years:6%
TTM:11%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:223%
Stock Price CAGR
10 Years:10%
5 Years:20%
3 Years:19%
1 Year:103%
Return on Equity
10 Years:-1%
5 Years:-2%
3 Years:-7%
Last Year:-15%

Last Updated: September 5, 2025, 1:30 am

Balance Sheet

Last Updated: December 10, 2025, 2:30 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 9101010121212131616171919
Reserves 84125167202359359391631732804848883871
Borrowings 150160180331373461539550646801683681672
Other Liabilities 126131123126273255290282396425424454476
Total Liabilities 3694264796691,0161,0871,2321,4751,7902,0451,9722,0372,037
Fixed Assets 83106140201278272306584601858816704700
CWIP 22325814591792421543461015
Investments 1111911511777886169
Other Assets 2623163134426097457408619661,1361,1021,2621,253
Total Assets 3694264796691,0161,0871,2321,4751,7902,0451,9722,0372,037

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 274672-9-15-9861171455113927
Cash from Investing Activity + -32-26-66-70-149-2-90-133-249-125-66-75
Cash from Financing Activity + -6-15-7911822633913660-8672
Net Cash Flow -124-1131815-12332-14-1324
Free Cash Flow -7195-39-34-78-4834-68-9379-16
CFO/OP 58%68%91%5%-33%10%77%82%111%34%110%30%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-87.00-76.00-88.00-299.00-357.00-388.00-404.00-363.00-488.00-590.00-513.00-461.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 7374569910486888377667272
Inventory Days 145184311277207219204200178255256233
Days Payable 13214417111015412711999112129154162
Cash Conversion Cycle 85114196266157178173184143192174143
Working Capital Days -4121-61943225540425135
ROCE %28%28%24%5%0%7%11%13%10%10%8%11%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 17.64%16.52%48.03%48.03%48.04%48.03%48.03%48.03%49.09%49.09%49.08%48.03%
FIIs 10.18%10.11%1.61%0.99%1.69%1.01%0.81%0.76%1.47%2.88%2.11%2.12%
DIIs 12.32%9.31%3.89%3.75%4.55%4.88%4.23%3.38%3.83%4.14%5.48%7.77%
Government 0.03%0.03%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public 59.82%64.01%46.46%47.22%45.73%46.07%46.93%47.83%45.61%43.88%43.33%42.07%
No. of Shareholders 52,92152,27857,09862,09858,16562,68767,75061,89358,11159,53857,66152,357

Shareholding Pattern Chart

No. of Shareholders

Camlin Fine Sciences Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
ICICI Prudential Commodities Fund 4,624,431 1.89 67.182,957,1882025-12-15 01:00:0556.38%
Franklin India Opportunities Fund 3,135,785 0.55 45.552,764,1662025-12-15 01:00:0513.44%
ICICI Prudential Multicap Fund 2,665,909 0.24 38.731,802,3092025-12-15 01:00:0547.92%
Franklin India Multi Cap Fund 1,581,171 0.47 22.97N/AN/AN/A
JM Small Cap Fund 504,008 1.17 7.32N/AN/AN/A
ICICI Prudential Retirement Fund - Pure Equity 313,993 0.28 4.56N/AN/AN/A
ICICI Prudential MidCap Fund 82,527 0.02 1.2N/AN/AN/A
ICICI Prudential Business Cycle Fund 50,000 0 0.73N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) -8.03-5.583.454.654.13
Diluted EPS (Rs.) -7.95-5.503.414.563.68
Cash EPS (Rs.) -5.04-1.576.517.428.60
Book Value[Excl.RevalReserv]/Share (Rs.) 47.8148.2948.1843.2647.81
Book Value[Incl.RevalReserv]/Share (Rs.) 47.8150.9752.2548.5255.67
Revenue From Operations / Share (Rs.) 88.6896.32107.0489.9593.11
PBDIT / Share (Rs.) 11.845.3413.4411.8414.66
PBIT / Share (Rs.) 8.450.649.468.2711.19
PBT / Share (Rs.) 2.61-5.935.125.998.24
Net Profit / Share (Rs.) -8.44-6.262.533.855.13
NP After MI And SOA / Share (Rs.) -7.40-5.543.323.874.00
PBDIT Margin (%) 13.355.5412.5513.1615.74
PBIT Margin (%) 9.520.678.839.1912.01
PBT Margin (%) 2.94-6.154.776.668.85
Net Profit Margin (%) -9.51-6.502.364.285.50
NP After MI And SOA Margin (%) -8.34-5.753.094.294.29
Return on Networth / Equity (%) -15.47-11.356.929.169.43
Return on Capital Employeed (%) 13.470.8911.7210.7714.20
Return On Assets (%) -6.87-4.752.523.373.43
Long Term Debt / Equity (X) 0.290.400.540.580.50
Total Debt / Equity (X) 0.710.801.040.940.99
Asset Turnover Ratio (%) 0.830.800.460.480.52
Current Ratio (X) 1.401.371.371.501.66
Quick Ratio (X) 0.770.660.650.870.99
Inventory Turnover Ratio (X) 3.211.381.291.651.79
Interest Coverage Ratio (X) 2.231.483.615.204.98
Interest Coverage Ratio (Post Tax) (X) 1.590.081.852.692.74
Enterprise Value (Cr.) 3620.142050.952685.652687.502251.73
EV / Net Operating Revenue (X) 2.171.271.601.901.90
EV / EBITDA (X) 16.2722.9212.7214.4612.05
MarketCap / Net Operating Revenue (X) 1.890.921.191.551.50
Price / BV (X) 3.511.832.663.313.30
Price / Net Operating Revenue (X) 1.890.921.191.551.50
EarningsYield -0.04-0.060.020.020.02

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Camlin Fine Sciences Ltd as of April 3, 2026 is: ₹4,658.37

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 3, 2026, Camlin Fine Sciences Ltd is Undervalued by 4,467.03% compared to the current share price ₹102.00

Default values used*: Default value of 15% for ROE is used

Intrinsic Value of Camlin Fine Sciences Ltd as of April 3, 2026 is: ₹3,099.38

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 3, 2026, Camlin Fine Sciences Ltd is Undervalued by 2,938.61% compared to the current share price ₹102.00

Default values used*: Default value of 15% for ROE is used

Last 5 Year EPS CAGR: -33.47%

*Investments are subject to market risks

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Camlin Fine Sciences Ltd:
    1. Net Profit Margin: -9.51%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 13.47% (Industry Average ROCE: 12.98%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: -15.47% (Industry Average ROE: 25.4%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 1.59
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.77
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 822 (Industry average Stock P/E: 64.87)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.71
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Camlin Fine Sciences Ltd. is a Public Limited Listed company incorporated on 30/11/1993 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L74100MH1993PLC075361 and registration number is 075361. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 886.49 Cr. and Equity Capital is Rs. 18.79 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Chemicals - Speciality - OthersFloor 2 to 5, In GS Point, Mumbai Maharashtra 400098Contact not found
Management
NamePosition Held
Mr. Ashish DandekarChairman & Managing Director
Mr. Nirmal MomayaManaging Director
Mr. Arjun DukaneExecutive Director -Technical
Mr. Joseph Conrad D'souzaIndependent Director
Ms. Anagha DandekarNon Exe.Non Ind.Director
Mr. Harsha RaghavanNon Exe.Non Ind.Director
Mr. Jens Van NieuwenborghNon Exe.Non Ind.Director
Mr. Mahabaleshwar PalekarIndependent Director
Mr. Pradip KanakiaIndependent Director
Mr. Amol ShahIndependent Director
Ms. Radhika DudhatIndependent Director
Mr. Abeezar FaizullabhoyIndependent Director

FAQ

What is the intrinsic value of Camlin Fine Sciences Ltd?

Camlin Fine Sciences Ltd's intrinsic value (as of 03 April 2026) is ₹3099.38 which is 2938.61% higher the current market price of ₹102.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,951 Cr. market cap, FY2026-2027 high/low of ₹335/96.2, reserves of ₹871 Cr, and liabilities of ₹2,037 Cr.

What is the Market Cap of Camlin Fine Sciences Ltd?

The Market Cap of Camlin Fine Sciences Ltd is 1,951 Cr..

What is the current Stock Price of Camlin Fine Sciences Ltd as on 03 April 2026?

The current stock price of Camlin Fine Sciences Ltd as on 03 April 2026 is ₹102.

What is the High / Low of Camlin Fine Sciences Ltd stocks in FY 2026-2027?

In FY 2026-2027, the High / Low of Camlin Fine Sciences Ltd stocks is ₹335/96.2.

What is the Stock P/E of Camlin Fine Sciences Ltd?

The Stock P/E of Camlin Fine Sciences Ltd is 822.

What is the Book Value of Camlin Fine Sciences Ltd?

The Book Value of Camlin Fine Sciences Ltd is 46.3.

What is the Dividend Yield of Camlin Fine Sciences Ltd?

The Dividend Yield of Camlin Fine Sciences Ltd is 0.00 %.

What is the ROCE of Camlin Fine Sciences Ltd?

The ROCE of Camlin Fine Sciences Ltd is 11.0 %.

What is the ROE of Camlin Fine Sciences Ltd?

The ROE of Camlin Fine Sciences Ltd is 15.0 %.

What is the Face Value of Camlin Fine Sciences Ltd?

The Face Value of Camlin Fine Sciences Ltd is 1.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Camlin Fine Sciences Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports